Indranil Sinha
Affiliations: | Karolinska Institute, Stockholm, Sweden |
Area:
Epigenetics / histone modification patternsGoogle:
"Indranil Sinha"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wahlund M, Sinha I, Broliden K, et al. (2020) The Feasibility of Host Transcriptome Profiling as a Diagnostic Tool for Microbial Etiology in Childhood Cancer Patients with Febrile Neutropenia. International Journal of Molecular Sciences. 21 |
| Bagchi D, Mason BD, Baldino K, et al. (2020) Adult-Onset Myopathy with Constitutive Activation of Akt following the Loss of hnRNP-U. Iscience. 23: 101319 |
| Toledo EM, Yang S, Gyllborg D, et al. (2020) Srebf1 Controls Midbrain Dopaminergic Neurogenesis. Cell Reports. 31: 107601 |
| Panayi AC, Smit L, Hays N, et al. (2019) A Porous Collagen-GAG Scaffold Promotes Muscle Regeneration Following Volumetric Muscle Loss Injury. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society |
| Kerr AG, Sinha I, Dadvar S, et al. (2019) Epigenetic regulation of diabetogenic adipose morphology. Molecular Metabolism |
| He H, Song D, Sinha I, et al. (2019) Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1. Oncogene |
| Bialesova L, Kulyté A, Petrus P, et al. (2017) Epigenetic Regulation of PLIN 1 in Obese Women and its Relation to Lipolysis. Scientific Reports. 7: 10152 |
| Kone A, Dara A, Niangaly A, et al. (2017) EFFECT OF ARTESUNATE MONOTHERAPY ONPLASMODIUM FALCIPARUMIN VIVO GENOMIC EXPRESSION Bmj Global Health. 2: A17.3-A18 |
| Qiao Y, He H, Jonsson P, et al. (2016) AP-1 is a key regulator of proinflammatory cytokine TNFα-mediated triple-negative breast cancer progression. The Journal of Biological Chemistry |
| Heshmati Y, Turköz G, Harisankar A, et al. (2016) Identification of CHD4 As a Potential Therapeutic Target of Acute Myeloid Leukemia Blood. 128: 1648-1648 |